ID LCF2_YEAST Reviewed; 744 AA. AC P39518; D3DLR3; DT 01-FEB-1995, integrated into UniProtKB/Swiss-Prot. DT 01-FEB-1995, sequence version 1. DT 27-MAR-2024, entry version 184. DE RecName: Full=Long-chain-fatty-acid--CoA ligase 2; DE EC=6.2.1.3 {ECO:0000269|PubMed:8206942}; DE AltName: Full=Fatty acid activator 2; DE AltName: Full=Long-chain acyl-CoA synthetase 2; GN Name=FAA2; Synonyms=FAM1; OrderedLocusNames=YER015W; OS Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast). OC Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes; OC Saccharomycetales; Saccharomycetaceae; Saccharomyces. OX NCBI_TaxID=559292; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=ATCC 204511 / S288c / AB972; RX PubMed=8027063; DOI=10.1016/s0021-9258(17)32414-6; RA Johnson D.R., Knoll L.J., Rowley N., Gordon J.I.; RT "Genetic analysis of the role of Saccharomyces cerevisiae acyl-CoA RT synthetase genes in regulating protein N-myristoylation."; RL J. Biol. Chem. 269:18037-18046(1994). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], MUTAGENESIS OF MET-1, AND SUBCELLULAR RP LOCATION. RC STRAIN=CW04; RX PubMed=7988550; DOI=10.1002/j.1460-2075.1994.tb06890.x; RA Harington A., Schwarz E., Slonimski P.P., Herbert C.J.; RT "Subcellular relocalization of a long-chain fatty acid CoA ligase by a RT suppressor mutation alleviates a respiration deficiency in Saccharomyces RT cerevisiae."; RL EMBO J. 13:5531-5538(1994). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=ATCC 204508 / S288c; RX PubMed=9169868; RA Dietrich F.S., Mulligan J.T., Hennessy K.M., Yelton M.A., Allen E., RA Araujo R., Aviles E., Berno A., Brennan T., Carpenter J., Chen E., RA Cherry J.M., Chung E., Duncan M., Guzman E., Hartzell G., Hunicke-Smith S., RA Hyman R.W., Kayser A., Komp C., Lashkari D., Lew H., Lin D., Mosedale D., RA Nakahara K., Namath A., Norgren R., Oefner P., Oh C., Petel F.X., RA Roberts D., Sehl P., Schramm S., Shogren T., Smith V., Taylor P., Wei Y., RA Botstein D., Davis R.W.; RT "The nucleotide sequence of Saccharomyces cerevisiae chromosome V."; RL Nature 387:78-81(1997). RN [4] RP GENOME REANNOTATION. RC STRAIN=ATCC 204508 / S288c; RX PubMed=24374639; DOI=10.1534/g3.113.008995; RA Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R., RA Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S., RA Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M., Cherry J.M.; RT "The reference genome sequence of Saccharomyces cerevisiae: Then and now."; RL G3 (Bethesda) 4:389-398(2014). RN [5] RP FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES. RX PubMed=8206942; DOI=10.1016/s0021-9258(17)34014-0; RA Knoll L.J., Johnson D.R., Gordon J.I.; RT "Biochemical studies of three Saccharomyces cerevisiae acyl-CoA RT synthetases, Faa1p, Faa2p, and Faa3p."; RL J. Biol. Chem. 269:16348-16356(1994). RN [6] RP INDUCTION, AND SUBCELLULAR LOCATION. RX PubMed=8670886; DOI=10.1002/j.1460-2075.1996.tb00755.x; RA Hettema E.H., van Roermund C.W.T., Distel B., van den Berg M., Vilela C., RA Rodrigues-Pousada C., Wanders R.J.A., Tabak H.F.; RT "The ABC transporter proteins Pat1 and Pat2 are required for import of RT long-chain fatty acids into peroxisomes of Saccharomyces cerevisiae."; RL EMBO J. 15:3813-3822(1996). RN [7] RP LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS]. RX PubMed=14562106; DOI=10.1038/nature02046; RA Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A., Dephoure N., RA O'Shea E.K., Weissman J.S.; RT "Global analysis of protein expression in yeast."; RL Nature 425:737-741(2003). RN [8] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=18407956; DOI=10.1074/mcp.m700468-mcp200; RA Albuquerque C.P., Smolka M.B., Payne S.H., Bafna V., Eng J., Zhou H.; RT "A multidimensional chromatography technology for in-depth phosphoproteome RT analysis."; RL Mol. Cell. Proteomics 7:1389-1396(2008). RN [9] RP FUNCTION. RX PubMed=22493507; DOI=10.1074/jbc.m111.332833; RA van Roermund C.W., Ijlst L., Majczak W., Waterham H.R., Folkerts H., RA Wanders R.J., Hellingwerf K.J.; RT "Peroxisomal fatty acid uptake mechanism in Saccharomyces cerevisiae."; RL J. Biol. Chem. 287:20144-20153(2012). RN [10] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=22814378; DOI=10.1073/pnas.1210303109; RA Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A., RA Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E., RA Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.; RT "N-terminal acetylome analyses and functional insights of the N-terminal RT acetyltransferase NatB."; RL Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012). CC -!- FUNCTION: Activates endogenous medium-chain (MCFA) and long-chain fatty CC acids (LCFA) by esterification of the fatty acids into metabolically CC active CoA-thioesters for subsequent degradation or incorporation into CC phospholipids (PubMed:8206942). Preferentially acts on C9:0-C13:0 fatty CC acids although C7:0-C17:0 fatty acids are tolerated (PubMed:8206942). CC Is the main if not exclusive MCFA (octanoate, decanoate and laureate) CC acyl-CoA ligase. Required for efficient MCFA beta-oxidation inside CC peroxisomes. Facilitates the transport of MCFAs into peroxisomes by CC passive diffusion, by decreasing the intraorganellar MCFA concentration CC (PubMed:8670886). Also esterifies LCFAs in the peroxisome matrix. The CC LCFAs are actively transported into peroxisomes by a PXA1-PXA2 CC heterodimeric transporter in the peroxisomal membrane CC (PubMed:22493507). {ECO:0000269|PubMed:22493507, CC ECO:0000269|PubMed:8206942, ECO:0000269|PubMed:8670886}. CC -!- CATALYTIC ACTIVITY: CC Reaction=a long-chain fatty acid + ATP + CoA = a long-chain fatty acyl- CC CoA + AMP + diphosphate; Xref=Rhea:RHEA:15421, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:57560, CC ChEBI:CHEBI:83139, ChEBI:CHEBI:456215; EC=6.2.1.3; CC Evidence={ECO:0000269|PubMed:8206942}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(9Z)-octadecenoate + ATP + CoA = (9Z)-octadecenoyl-CoA + AMP + CC diphosphate; Xref=Rhea:RHEA:33607, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:30823, ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, CC ChEBI:CHEBI:57387, ChEBI:CHEBI:456215; CC Evidence={ECO:0000269|PubMed:8206942}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33608; CC Evidence={ECO:0000305|PubMed:8206942}; CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + CoA + hexadecanoate = AMP + diphosphate + hexadecanoyl- CC CoA; Xref=Rhea:RHEA:30751, ChEBI:CHEBI:7896, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:57379, CC ChEBI:CHEBI:456215; Evidence={ECO:0000269|PubMed:8206942}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:30752; CC Evidence={ECO:0000305|PubMed:8206942}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(9Z)-hexadecenoate + ATP + CoA = (9Z)-hexadecenoyl-CoA + AMP + CC diphosphate; Xref=Rhea:RHEA:33647, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:32372, ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, CC ChEBI:CHEBI:61540, ChEBI:CHEBI:456215; CC Evidence={ECO:0000269|PubMed:8206942}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33648; CC Evidence={ECO:0000305|PubMed:8206942}; CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + CoA + tetradecanoate = AMP + diphosphate + CC tetradecanoyl-CoA; Xref=Rhea:RHEA:33619, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:30807, ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, CC ChEBI:CHEBI:57385, ChEBI:CHEBI:456215; CC Evidence={ECO:0000269|PubMed:8206942}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33620; CC Evidence={ECO:0000305|PubMed:8206942}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(9Z)-tetradecenoate + ATP + CoA = (9Z)-tetradecenoyl-CoA + AMP CC + diphosphate; Xref=Rhea:RHEA:33643, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:32370, ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, CC ChEBI:CHEBI:65060, ChEBI:CHEBI:456215; CC Evidence={ECO:0000269|PubMed:8206942}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33644; CC Evidence={ECO:0000305|PubMed:8206942}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(9Z,12Z)-octadecadienoate + ATP + CoA = (9Z,12Z)- CC octadecadienoyl-CoA + AMP + diphosphate; Xref=Rhea:RHEA:33651, CC ChEBI:CHEBI:30245, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, CC ChEBI:CHEBI:57287, ChEBI:CHEBI:57383, ChEBI:CHEBI:456215; CC Evidence={ECO:0000269|PubMed:8206942}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33652; CC Evidence={ECO:0000305|PubMed:8206942}; CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + CoA + dodecanoate = AMP + diphosphate + dodecanoyl-CoA; CC Xref=Rhea:RHEA:33623, ChEBI:CHEBI:18262, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:57375, CC ChEBI:CHEBI:456215; Evidence={ECO:0000269|PubMed:8206942}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33624; CC Evidence={ECO:0000305|PubMed:8206942}; CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + CoA + pentadecanoate = AMP + diphosphate + CC pentadecanoyl-CoA; Xref=Rhea:RHEA:44076, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:74309, CC ChEBI:CHEBI:78795, ChEBI:CHEBI:456215; CC Evidence={ECO:0000269|PubMed:8206942}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44077; CC Evidence={ECO:0000305|PubMed:8206942}; CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + CoA + undecanoate = AMP + diphosphate + undecanoyl-CoA; CC Xref=Rhea:RHEA:44080, ChEBI:CHEBI:30616, ChEBI:CHEBI:32369, CC ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:77547, CC ChEBI:CHEBI:456215; Evidence={ECO:0000269|PubMed:8206942}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44081; CC Evidence={ECO:0000305|PubMed:8206942}; CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + CoA + heptadecanoate = AMP + diphosphate + CC heptadecanoyl-CoA; Xref=Rhea:RHEA:44084, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:32366, ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, CC ChEBI:CHEBI:74307, ChEBI:CHEBI:456215; CC Evidence={ECO:0000269|PubMed:8206942}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44085; CC Evidence={ECO:0000305|PubMed:8206942}; CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + CoA + decanoate = AMP + decanoyl-CoA + diphosphate; CC Xref=Rhea:RHEA:33627, ChEBI:CHEBI:27689, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:61430, CC ChEBI:CHEBI:456215; Evidence={ECO:0000269|PubMed:8206942}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33628; CC Evidence={ECO:0000305|PubMed:8206942}; CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + CoA + octanoate = AMP + diphosphate + octanoyl-CoA; CC Xref=Rhea:RHEA:33631, ChEBI:CHEBI:25646, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:57386, CC ChEBI:CHEBI:456215; Evidence={ECO:0000269|PubMed:8206942}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33632; CC Evidence={ECO:0000305|PubMed:8206942}; CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + CoA + heptanoate = AMP + diphosphate + heptanoyl-CoA; CC Xref=Rhea:RHEA:44088, ChEBI:CHEBI:30616, ChEBI:CHEBI:32362, CC ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:78811, CC ChEBI:CHEBI:456215; Evidence={ECO:0000269|PubMed:8206942}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44089; CC Evidence={ECO:0000305|PubMed:8206942}; CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + CoA + nonadecanoate = AMP + diphosphate + nonadecanoyl- CC CoA; Xref=Rhea:RHEA:44092, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, CC ChEBI:CHEBI:57287, ChEBI:CHEBI:75105, ChEBI:CHEBI:78796, CC ChEBI:CHEBI:456215; Evidence={ECO:0000269|PubMed:8206942}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44093; CC Evidence={ECO:0000305|PubMed:8206942}; CC -!- COFACTOR: CC Name=Mg(2+); Xref=ChEBI:CHEBI:18420; CC Evidence={ECO:0000250|UniProtKB:P30624}; CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC pH dependence: CC Optimum pH is 7.1. {ECO:0000269|PubMed:8206942}; CC Temperature dependence: CC Optimum temperature is 25 degrees Celsius. CC {ECO:0000269|PubMed:8206942}; CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:7988550}. CC Peroxisome membrane {ECO:0000269|PubMed:8670886}; Peripheral membrane CC protein {ECO:0000269|PubMed:8670886}; Matrix side CC {ECO:0000269|PubMed:8670886}. Note=Imported via the peroxisome CC targeting signal type 1 (PTS1)-dependent protein import pathway. CC {ECO:0000269|PubMed:8670886}. CC -!- INDUCTION: By oleate. {ECO:0000269|PubMed:8670886}. CC -!- DOMAIN: The FACS motif is required for catalytic activity and substrate CC specificity. {ECO:0000250|UniProtKB:P30624}. CC -!- MISCELLANEOUS: Present with 358 molecules/cell in log phase SD medium. CC {ECO:0000269|PubMed:14562106}. CC -!- SIMILARITY: Belongs to the ATP-dependent AMP-binding enzyme family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; X77783; CAA54817.1; -; Genomic_DNA. DR EMBL; X82364; CAA57780.1; -; Genomic_DNA. DR EMBL; U18778; AAB64548.1; -; Genomic_DNA. DR EMBL; BK006939; DAA07667.1; -; Genomic_DNA. DR PIR; A54901; A54901. DR RefSeq; NP_010931.3; NM_001178906.3. DR AlphaFoldDB; P39518; -. DR SMR; P39518; -. DR BioGRID; 36747; 47. DR DIP; DIP-6565N; -. DR IntAct; P39518; 5. DR MINT; P39518; -. DR STRING; 4932.YER015W; -. DR SwissLipids; SLP:000001032; -. DR TCDB; 4.C.1.1.15; the fatty acid group translocation (fat) family. DR iPTMnet; P39518; -. DR MaxQB; P39518; -. DR PaxDb; 4932-YER015W; -. DR PeptideAtlas; P39518; -. DR EnsemblFungi; YER015W_mRNA; YER015W; YER015W. DR GeneID; 856734; -. DR KEGG; sce:YER015W; -. DR AGR; SGD:S000000817; -. DR SGD; S000000817; FAA2. DR VEuPathDB; FungiDB:YER015W; -. DR eggNOG; KOG1256; Eukaryota. DR GeneTree; ENSGT00960000189179; -. DR HOGENOM; CLU_000022_45_4_1; -. DR InParanoid; P39518; -. DR OMA; IMARTTY; -. DR OrthoDB; 443463at2759; -. DR BioCyc; MetaCyc:YER015W-MONOMER; -. DR BioCyc; YEAST:YER015W-MONOMER; -. DR BRENDA; 6.2.1.3; 984. DR Reactome; R-SCE-2046105; Linoleic acid (LA) metabolism. DR Reactome; R-SCE-2046106; alpha-linolenic acid (ALA) metabolism. DR Reactome; R-SCE-75876; Synthesis of very long-chain fatty acyl-CoAs. DR BioGRID-ORCS; 856734; 1 hit in 10 CRISPR screens. DR PRO; PR:P39518; -. DR Proteomes; UP000002311; Chromosome V. DR RNAct; P39518; Protein. DR GO; GO:0005783; C:endoplasmic reticulum; IBA:GO_Central. DR GO; GO:0016020; C:membrane; IBA:GO_Central. DR GO; GO:0005739; C:mitochondrion; HDA:SGD. DR GO; GO:0005778; C:peroxisomal membrane; IEA:UniProtKB-SubCell. DR GO; GO:0005777; C:peroxisome; IDA:SGD. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW. DR GO; GO:0102391; F:decanoate-CoA ligase activity; IEA:RHEA. DR GO; GO:0004467; F:long-chain fatty acid-CoA ligase activity; IDA:SGD. DR GO; GO:0031956; F:medium-chain fatty acid-CoA ligase activity; IDA:SGD. DR GO; GO:0031957; F:very long-chain fatty acid-CoA ligase activity; IGI:SGD. DR GO; GO:0006635; P:fatty acid beta-oxidation; IMP:UniProtKB. DR GO; GO:0015916; P:fatty-acyl-CoA transport; IGI:UniProtKB. DR GO; GO:0015910; P:long-chain fatty acid import into peroxisome; IGI:UniProtKB. DR GO; GO:0001676; P:long-chain fatty acid metabolic process; IMP:SGD. DR GO; GO:0042760; P:very long-chain fatty acid catabolic process; IGI:UniProtKB. DR CDD; cd05927; LC-FACS_euk; 1. DR Gene3D; 3.40.50.12780; N-terminal domain of ligase-like; 1. DR InterPro; IPR020845; AMP-binding_CS. DR InterPro; IPR000873; AMP-dep_Synth/Lig_com. DR InterPro; IPR042099; ANL_N_sf. DR InterPro; IPR045311; LC-FACS_euk. DR PANTHER; PTHR43272; LONG-CHAIN-FATTY-ACID--COA LIGASE; 1. DR PANTHER; PTHR43272:SF3; LONG-CHAIN-FATTY-ACID--COA LIGASE 5; 1. DR Pfam; PF00501; AMP-binding; 1. DR SUPFAM; SSF56801; Acetyl-CoA synthetase-like; 1. DR PROSITE; PS00455; AMP_BINDING; 1. PE 1: Evidence at protein level; KW ATP-binding; Cytoplasm; Fatty acid metabolism; Ligase; Lipid metabolism; KW Magnesium; Membrane; Nucleotide-binding; Peroxisome; Reference proteome. FT CHAIN 1..744 FT /note="Long-chain-fatty-acid--CoA ligase 2" FT /id="PRO_0000193120" FT MOTIF 567..617 FT /note="FACS" FT /evidence="ECO:0000250|UniProtKB:P30624" FT MOTIF 742..744 FT /note="C-terminal peroxisome targeting signal (PTS1)" FT /evidence="ECO:0000305|PubMed:8670886" FT BINDING 299..310 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:P69451" FT MUTAGEN 1 FT /note="M->MWKNAGYKKRIRTNLFRNM: In FAM1-1; extragenic FT suppressor mutation, which creates a new initiation codon FT and adds 18 amino acids to the N-terminus of the protein. FT This extension has all the characteristics of a FT mitochondrial targeting sequence and the FAM1-1 mutant FT protein is indeed imported into the mitochondria, where it FT restores respiratory growth to a deletion of the FT mitochondrial beta-keto-acyl synthase CEM1." FT /evidence="ECO:0000269|PubMed:7988550" SQ SEQUENCE 744 AA; 83438 MW; 1E023C18682805BC CRC64; MAAPDYALTD LIESDPRFES LKTRLAGYTK GSDEYIEELY SQLPLTSYPR YKTFLKKQAV AISNPDNEAG FSSIYRSSLS SENLVSCVDK NLRTAYDHFM FSARRWPQRD CLGSRPIDKA TGTWEETFRF ESYSTVSKRC HNIGSGILSL VNTKRKRPLE ANDFVVAILS HNNPEWILTD LACQAYSLTN TALYETLGPN TSEYILNLTE APILIFAKSN MYHVLKMVPD MKFVNTLVCM DELTHDELRM LNESLLPVKC NSLNEKITFF SLEQVEQVGC FNKIPAIPPT PDSLYTISFT SGTTGLPKGV EMSHRNIASG IAFAFSTFRI PPDKRNQQLY DMCFLPLAHI FERMVIAYDL AIGFGIGFLH KPDPTVLVED LKILKPYAVA LVPRILTRFE AGIKNALDKS TVQRNVANTI LDSKSARFTA RGGPDKSIMN FLVYHRVLID KIRDSLGLSN NSFIITGSAP ISKDTLLFLR SALDIGIRQG YGLTETFAGV CLSEPFEKDV GSCGAIGISA ECRLKSVPEM GYHADKDLKG ELQIRGPQVF ERYFKNPNET SKAVDQDGWF STGDVAFIDG KGRISVIDRV KNFFKLAHGE YIAPEKIENI YLSSCPYITQ IFVFGDPLKT FLVGIVGVDV DAAQPILAAK HPEVKTWTKE VLVENLNRNK KLRKEFLNKI NKCTDGLQGF EKLHNIKVGL EPLTLEDDVV TPTFKIKRAK ASKFFKDTLD QLYAEGSLVK TEKL //